Blood Clues – What Biomarkers Tell Us About Stroke and MI Risk

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00037499

Enrollment

600

Registered

2026-01-05

Start date

2026-01-01

Completion date

Unknown

Last updated

2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I63

Interventions

Group 1: Ischemic Stroke Patients Group 2: Myocardial Infarction Patients

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Ischemic Stroke Myocardial Infarction

Exclusion criteria

Exclusion criteria: Hemorrhagic Stroke Incomplete oder inplausible laboratory data

Design outcomes

Primary

Measure	Time frame
Difference in Lipoprotein(a) serum concentrations and other biomarkers between patients with ischemic stroke and those with myocardial infarction at the time of hospital admission.	—

Secondary

Measure	Time frame
Analysis of biomarkers in relation to the underlying etiology of ischemic stroke (e.g., TOAST classification: large-artery atherosclerosis, cardioembolism, cryptogenic, etc.) and infarction type (STEMI vs. NSTEMI).	—

Countries

Austria

Contacts

Public ContactBenjamin Matosevic

LKH Feldkirch

benjamin.matosevic@lkhf.at+43 5522 4030

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026